These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11246681)

  • 1. Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone.
    Theander E; Brucato A; Gudmundsson S; Salomonsson S; Wahren-Herlenius M; Manthorpe R
    J Rheumatol; 2001 Feb; 28(2):373-6. PubMed ID: 11246681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intrauterine therapy and outcome in four pregnancies of one mother with anti ro-autoantibody positive Sjoegren's syndrome].
    Zemlin M; Bauer K; Dörner T; Altinöz H; Versmold H
    Z Geburtshilfe Neonatol; 2002; 206(1):22-5. PubMed ID: 11887252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound findings in fetal congenital heart block associated with maternal anti-Ro/SSA and Anti-La/SSB antibodies.
    Lai J; Clark TJ; Tan JH; Delaney S; Jolley JA
    Ultrasound Q; 2015 Mar; 31(1):34-6. PubMed ID: 25706362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.
    Skog A; Wahren-Herlenius M; Sundström B; Bremme K; Sonesson SE
    Pediatrics; 2008 Apr; 121(4):e803-9. PubMed ID: 18381509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult heart block is associated with disease activity in primary Sjögren's syndrome.
    Lodde BM; Sankar V; Kok MR; Leakan RA; Tak PP; Pillemer SR
    Scand J Rheumatol; 2005; 34(5):383-6. PubMed ID: 16234186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease.
    Jaeggi ET; Fouron JC; Silverman ED; Ryan G; Smallhorn J; Hornberger LK
    Circulation; 2004 Sep; 110(12):1542-8. PubMed ID: 15353508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.
    Chang YL; Hsieh PC; Chang SD; Chao AS; Liang CC; Soong YK
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):167-71. PubMed ID: 16219517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
    Meyer O
    Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome.
    Makino S; Yonemoto H; Itoh S; Takeda S
    Acta Obstet Gynecol Scand; 2007; 86(9):1145-6. PubMed ID: 17712660
    [No Abstract]   [Full Text] [Related]  

  • 11. Congenital fetal heart block: a potential therapeutic role for intravenous immunoglobulin.
    David AL; Ataullah I; Yates R; Sullivan I; Charles P; Williams D
    Obstet Gynecol; 2010 Aug; 116 Suppl 2():543-547. PubMed ID: 20664449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete heart block in a fetus associated with maternal Sjögren's syndrome.
    Veille JC; Sunderland C; Bennett RM
    Am J Obstet Gynecol; 1985 Mar; 151(5):660-1. PubMed ID: 3872074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
    Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
    J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neonatal antinuclear antibodies and the lupus syndrome].
    Pennec Y; Colin A; Youinou P; Alix D
    Arch Fr Pediatr; 1985; 42(7):517-9. PubMed ID: 3878694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of recurrent congenital heart block in a SSA/SSB positive mother using high dose maternal IVIG from 16-week gestation.
    Sterling RA; Carlin A
    Prenat Diagn; 2015 Nov; 35(11):1148-50. PubMed ID: 26179183
    [No Abstract]   [Full Text] [Related]  

  • 16. More to death than dying: apoptosis in the pathogenesis of SSA/Ro-SSB/La-associated congenital heart block.
    Clancy RM; Buyon JP
    Rheum Dis Clin North Am; 2004 Aug; 30(3):589-602, x. PubMed ID: 15261343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus.
    Saleeb S; Copel J; Friedman D; Buyon JP
    Arthritis Rheum; 1999 Nov; 42(11):2335-45. PubMed ID: 10555029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful preventive treatment of congenital heart block during pregnancy in a woman with systemic lupus erythematosus and anti-Sjögren's syndrome A/Ro antibody.
    Yang CH; Chen JY; Lee SC; Luo SF
    J Microbiol Immunol Infect; 2005 Oct; 38(5):365-9. PubMed ID: 16211147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature.
    Breur JM; Visser GH; Kruize AA; Stoutenbeek P; Meijboom EJ
    Ultrasound Obstet Gynecol; 2004 Sep; 24(4):467-72. PubMed ID: 15343606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern.
    Ambrosi A; Salomonsson S; Eliasson H; Zeffer E; Skog A; Dzikaite V; Bergman G; Fernlund E; Tingström J; Theander E; Rydberg A; Skogh T; Öhman A; Lundström U; Mellander M; Winqvist O; Fored M; Ekbom A; Alfredsson L; Källberg H; Olsson T; Gadler F; Jonzon A; Kockum I; Sonesson SE; Wahren-Herlenius M
    Ann Rheum Dis; 2012 Mar; 71(3):334-40. PubMed ID: 21953338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.